Bioera Past Earnings Performance

Past criteria checks 0/6

Bioera's earnings have been declining at an average annual rate of -0.7%, while the Personal Products industry saw earnings growing at 6.6% annually. Revenues have been declining at an average rate of 53.4% per year.

Key information

-0.7%

Earnings growth rate

-147.8%

EPS growth rate

Personal Products Industry Growth6.6%
Revenue growth rate-53.4%
Return on equityn/a
Net Margin-657.9%
Last Earnings Update31 Dec 2022

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Bioera makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:BIEM Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 221-400
30 Sep 221-1810
30 Jun 221-1810
31 Mar 221-910
31 Dec 211010
30 Sep 2131410
30 Jun 2151520
31 Mar 218620
31 Dec 2011-430
30 Sep 2014-430
30 Jun 2017-430
31 Mar 2022-530
31 Dec 1927-540
30 Sep 1931-540
30 Jun 1934-550
31 Mar 1937-550
31 Dec 1840-460
30 Sep 1841-460
30 Jun 1843-560
31 Mar 1845-560
31 Dec 1746-570
30 Sep 1747-470
30 Jun 1749-480
31 Mar 1751-380
31 Dec 1653-380
30 Sep 1655-380
30 Jun 1657-380
31 Mar 1657-380
31 Dec 1557-390
30 Sep 1556-390
30 Jun 1555-390
31 Mar 1554-380
31 Dec 1452-280
30 Sep 1450-170
30 Jun 1449070
31 Mar 1448060
31 Dec 1347160
30 Sep 1347-160
30 Jun 1347-260
31 Mar 1346-160
31 Dec 1246160

Quality Earnings: BIEM is currently unprofitable.

Growing Profit Margin: BIEM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BIEM is unprofitable, and losses have increased over the past 5 years at a rate of 0.7% per year.

Accelerating Growth: Unable to compare BIEM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BIEM is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (42%).


Return on Equity

High ROE: BIEM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/12/26 20:31
End of Day Share Price 2023/09/28 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bioera S.p.A. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.